July 2023 Investor Presentation

Sales in CHF million Operating performance Taste & Wellbeing EBITDA 786 778 in CHF million +5.2% LFL growth 3,861 3,593 FY 2021 FY 2022 21.9% EBITDA Margin 20.1% 22.4% Comparable EBITDA Margin 20.3% July 2023 Investor Presentation Sales of CHF 3,861 million, an increase of 5.2% on a like- for-like basis and of 7.5% in Swiss francs * EBITDA of CHF 778 million, compared to CHF 786 million in 2021 Acquisition and restructuring costs of CHF 6 million, compared to CHF 20 million in 2021 EBITDA margin of 20.1% compared to 21.9% in 2021. The comparable EBITDA margin was 20.3% versus 22.4% in 2021 Givaudan As % of sales * Like-for-like: excludes the impact of currency, acquisitions and disposals 52 2

View entire presentation